PACS Group, Inc.(US:PACS) Prnewswireยท2024-12-23 10:45Core Points - The Gross Law Firm is notifying shareholders of PACS Group, Inc. regarding a class action lawsuit related to alleged misleading statements and fraudulent practices [5] - The lawsuit covers shareholders who purchased PACS stock during the class period from April 11, 2024, to November 5, 2024 [3] Allegations - The complaint alleges that PACS engaged in a scheme to submit false Medicare claims, which accounted for over 100% of the company's operating and net income from 2020 to 2023 [6] - It is claimed that PACS billed for unnecessary respiratory and sensory integration therapies to Medicare [6] - The company is also accused of falsifying documentation related to licensure and staffing [6] - As a result of these actions, the positive statements made by the defendants about the company's business and prospects were materially misleading [6] Next Steps for Shareholders - Shareholders who purchased PACS shares during the specified timeframe are encouraged to register for the class action and will be enrolled in a portfolio monitoring software for updates [4] - The deadline to seek lead plaintiff status is January 13, 2025, and there is no cost or obligation to participate in the case [4]